Cargando…

Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects

The inefficiency of recombinant tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based clinical regimens has been dominantly attributed to the short half-life of TRAIL. Affinity-controlled release using endogenous long-acting proteins, such as IgG and albumin, as carriers is extremely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hao, Feng, Yanru, Cai, Huawei, Jia, Dianlong, Li, Heng, Tao, Ze, Zhong, Yi, Li, Zhao, Shi, Qiuxiao, Wan, Lin, Li, Lin, Lu, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928902/ https://www.ncbi.nlm.nih.gov/pubmed/29721092 http://dx.doi.org/10.7150/thno.23880

Ejemplares similares

Targeted Delivery to Tumor-associated Pericytes via an Affibody with High Affinity for PDGFRβ Enhances the in vivo Antitumor Effects of Human TRAIL
por: Tao, Ze, et al.
Publicado: (2017)

Combination of long-acting TRAIL and tumor cell-targeted photodynamic therapy as a novel strategy to overcome chemotherapeutic multidrug resistance and TRAIL resistance of colorectal cancer
por: She, Tianshan, et al.
Publicado: (2021)

A novel tumor-homing TRAIL variant eradicates tumor xenografts of refractory colorectal cancer cells in combination with tumor cell-targeted photodynamic therapy
por: Li, Zhao, et al.
Publicado: (2022)

IgG-single-chain TRAIL fusion proteins for tumour therapy
por: Siegemund, Martin, et al.
Publicado: (2018)

Universal chimeric Fcγ receptor T cells with appropriate affinity for IgG1 antibody exhibit optimal antitumor efficacy
por: Zhu, Wen, et al.
Publicado: (2023)

Targeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiation
por: Cai, Chun-Miao, et al.
Publicado: (2016)

IFN-γ-Secreting-Mesenchymal Stem Cells Exert an Antitumor Effect In Vivo via the TRAIL Pathway
por: Yang, Xinyuan, et al.
Publicado: (2014)

Mouse IgG2c Fc loop residues promote greater receptor-binding affinity than mouse IgG2b or human IgG1
por: Falconer, Daniel J., et al.
Publicado: (2018)

The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells
por: Legler, Karen, et al.
Publicado: (2018)

Correction: Mouse IgG2c Fc loop residues promote greater receptor-binding affinity than mouse IgG2b or human IgG1
Publicado: (2018)

Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL
por: TATSUTA, TAKEO, et al.
Publicado: (2013)

Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC
por: Liu, Shuang, et al.
Publicado: (2021)

Modulation of Immunoglobulin (Ig)E-mediated Systemic Anaphylaxis by Low-Affinity Fc Receptors for IgG
por: Ujike, Azusa, et al.
Publicado: (1999)

Development and Validation of an Affinity Chromatography-Protein G Method for IgG Quantification
por: Paradina Fernández, Lesly, et al.
Publicado: (2014)

Serum IgG Subclasses in Autoimmune Diseases
por: Zhang, Haoze, et al.
Publicado: (2015)

Complement Activation Selectively Potentiates the Pathogenicity of the IgG2b and IgG3 Isotypes of a High Affinity Anti-Erythrocyte Autoantibody
por: da Silveira, Samareh Azeredo, et al.
Publicado: (2002)

The influence of antibody fragment format on phage display based affinity maturation of IgG
por: Steinwand, Miriam, et al.
Publicado: (2014)

Evolutionary Story of the Low/Medium-Affinity IgG Fc Receptor Gene Cluster
por: Lejeune, Julien, et al.
Publicado: (2019)

Enhancement of Immune Effector Functions by Modulating IgG’s Intrinsic Affinity for Target Antigen
por: Mazor, Yariv, et al.
Publicado: (2016)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

The Expression of IgG and IgG4 in Orbital MALT Lymphoma: The Similarities and Differences of IgG4-Related Diseases
por: Li, Kai-Ming, et al.
Publicado: (2020)

Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity
por: Siegemund, M, et al.
Publicado: (2012)

Superior vena cava stenting in IgG4-associated mediastinal fibrosis
por: Khalid, Mohammed, et al.
Publicado: (2020)

IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease
por: Peng, Linyi, et al.
Publicado: (2020)

Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
por: Zhao, JianGuo, et al.
Publicado: (2023)

Mechanistic modeling of a human IgG(4) monoclonal antibody (tralokinumab) Fab‐arm exchange with endogenous IgG(4) in healthy volunteers
por: Wang, Bing, et al.
Publicado: (2022)

Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues
por: Kallolimath, Somanath, et al.
Publicado: (2023)

Titrating CD47 by mismatch CRISPR-interference reveals incomplete repression can eliminate IgG-opsonized tumors but limits induction of antitumor IgG
por: Hayes, Brandon H, et al.
Publicado: (2023)

Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis
por: Fichtner, Miriam L., et al.
Publicado: (2020)

The antiinflammatory activity of IgG: the intravenous IgG paradox
por: Nimmerjahn, Falk, et al.
Publicado: (2007)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)

Optimization of Sequence, Display, and Mode of Operation of IgG-Binding Peptide Ligands to Develop Robust, High-Capacity Affinity Adsorbents That Afford High IgG Product Quality
por: Islam, Tuhidul, et al.
Publicado: (2019)

Sialylated IgG in epithelial cancers inhibits antitumor function of T cells via Siglec‐7
por: Fan, Tianrui, et al.
Publicado: (2022)

Mast Cells Exhibiting Strong Cytoplasmic Staining for IgE and High Affinity IgE Receptor are Increased in IgG4-Related Disease
por: Nishida, Kenji, et al.
Publicado: (2018)

Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG
por: Brandsma, Arianne M., et al.
Publicado: (2019)

Enriched blood IgG sialylation attenuates IgG-mediated and IgG-controlled-IgE-mediated allergic reactions
por: Petry, Janina, et al.
Publicado: (2020)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

Purple sweet potato anthocyanin exerts antitumor effect in bladder cancer
por: Li, Wei-Lin, et al.
Publicado: (2018)

Isotype switching: Mouse IgG3 constant region drives increased affinity for polysaccharide antigens
por: Harmer, Nicholas J., et al.
Publicado: (2016)

Antigen physiochemical properties allosterically effect the IgG Fc-region and Fc neonatal receptor affinity
por: Sun, Yue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bd6jresn4d8l94e6ioba7b64f7